Central Nervous System Involvement of Granulomatosis with Polyangiitis: Clinical-radiological Presentation Distinguishes Different Outcomes
Overview
Authors
Affiliations
Objective: The aim of this study was to describe the presentation and outcomes of patients with granulomatosis with polyangiitis (GPA) presenting with CNS involvement.
Methods: Patients were included in this nationwide retrospective study if they had GPA according to ACR criteria and/or the European Medicines Agency algorithm and CNS involvement.
Results: Thirty-five patients were included in the study. CNS involvement was observed in 51% of patients at GPA diagnosis. Headache (66%) was the main symptom, followed by sensory (43%) and motor impairment (31%). CNS involvement was characterized by pachymeningitis in 20, cerebral ischaemic lesions in 15 and haemorrhagic lesions in 2, with hypophyseal involvement in 2 patients. According to the clinical-radiological presentation, we distinguished granulomatous (G-CNS) and vasculitic (V-CNS) phenotypes. G-CNS patients more frequently had headaches, while V-CNS patients more frequently had motor impairment and renal involvement. Induction therapy produced clinical responses in 86% of patients. Baseline modified Rankin scale was higher for V-CNS than G-CNS patients (3 vs 2, P = 0.002). Initial spinal cord pachymeningitis was significantly associated with the need for a new induction regimen for relapsing/refractory disease (P = 0.01). Long-term neurological sequelae were noted in 51% of patients, including 35% with G-CNS and 69% with V-CNS (P = 0.08). Neurological sequelae were mainly noted in cases of spinal cord pachymeningitis (100%) and ischaemic or haemorrhagic lesions (73%).
Conclusion: The clinical-radiological phenotype distinguished different long-term outcomes in patients with GPA and CNS involvement. Long-term neurological sequelae persisted in half of patients, mainly those with spinal cord pachymeningitis and vasculitic lesions.
Xu J, Li S, Ge Y, Cui X, Wang G, Chen F Heliyon. 2024; 10(23):e40801.
PMID: 39687139 PMC: 11648878. DOI: 10.1016/j.heliyon.2024.e40801.
Chen Y, Gou L, Wang L, Qian M, Wu Q, Zheng W Arthritis Res Ther. 2024; 26(1):6.
PMID: 38169421 PMC: 10759605. DOI: 10.1186/s13075-023-03239-9.
Seifert R, Rauch M, Klingebiel R, Boese L, Greeve I, Rudwaleit M Front Neurol. 2023; 14:1277843.
PMID: 38020617 PMC: 10666051. DOI: 10.3389/fneur.2023.1277843.
Primary angiitis of the CNS and ANCA-associated vasculitis: from pathology to treatment.
Sherri A, Mortada M, Makowska J, Lewandowska-Polak A Rheumatol Int. 2023; 44(2):211-222.
PMID: 37777632 PMC: 10796583. DOI: 10.1007/s00296-023-05461-9.
Yuan D, Ji Q, Xia J, Wang J, Liang N Open Life Sci. 2023; 18(1):20220654.
PMID: 37483427 PMC: 10358746. DOI: 10.1515/biol-2022-0654.